Tekla Life Sciences Investors
Tekla Life Sciences Investors (HQL) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0000884121 · HQL · NYSE · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0000884121 · Updated hourly · Not investment advice
Latest Key Filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Tekla Life Sciences Investors (NYSE: HQL) has submitted 512 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1992. As a Financial Services sector company with CIK 0000884121, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Tekla Life Sciences Investors's most comprehensive regulatory disclosure. The most recent Tekla Life Sciences Investors 10-K was filed on — for fiscal year ending —. Historical HQL 10-K annual reports are available from 1995 through —.
Investors researching Tekla Life Sciences Investors SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
HQL SEC Filings · 8 questionsTekla Life Sciences Investors (HQL) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 512 filings and access original documents at no cost. Tekla Life Sciences Investors's CIK is 0000884121.